104
Participants
Start Date
December 31, 2003
Study Completion Date
April 30, 2005
recombinant B-type, natriuretic peptide
The intravenous infusion of nesiritide consisted of a bolus dose of 2mcg/kg followed by the infusion rate of 0.01 mcg/kg/min for up to eight hours. The nesiritide was mixed in 250 ml of 0.9% normal saline solution.
placebo
The intravenous infusion of placebo consisted of a bolus dose of 2mcg/kg followed by the infusion rate of 0.01 mcg/kg/min for up to eight hours. The placebo was mixed in 250 ml of 0.9% normal saline solution.
Parkland Hospital, Dallas
Scios, Inc.
INDUSTRY
University of Texas Southwestern Medical Center
OTHER